Clinical Trial Update: Safety, Effectiveness and Quality of Life of Trastuzumab Deruxtecan in Patients with HER2+ Breast Cancer

View source ↗

Summary

This clinical trial update reports on safety, effectiveness, and quality of life for trastuzumab deruxtecan in patients with HER2-positive breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Trastuzumab deruxtecan (trastuzumab deruxtecan)

Snippet

Sponsor: Daiichi Sankyo France | Conditions: HER2-positive Breast Cancer | Status: COMPLETED